


Ask a doctor about a prescription for CALCIPOTRIOL/BETAMETHASONE RATIOPHARM 50 micrograms/g + 0.5 mg/g OINTMENT
Package Leaflet: Information for theuser
Calcipotriol/Betamethasone ratiopharm 50 micrograms/g + 0.5 mg/g ointment
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Calcipotriol/Betamethasone ratiopharm is used on the skin to treat plaque psoriasis (psoriasis vulgaris) in adults. The cause of psoriasis is the excessively rapid production of your skin cells. This causes redness, scaling, and thickening of your skin.
Calcipotriol/Betamethasone ratiopharm contains calcipotriol and betamethasone. Calcipotriol helps to normalize the rate of skin cell growth and betamethasone reduces inflammation.
Do not use Calcipotriol/Betamethasone ratiopharm
Since Calcipotriol/Betamethasone ratiopharm contains a potent steroid, DO NOT use it on skin affected by:
Warnings and precautions
Consult your doctor, pharmacist, or nurse before and during the use of Calcipotriol/Betamethasone ratiopharm
Special precautions
Children and adolescents
Calcipotriol/Betamethasone ratiopharm is not recommended for use in children under 18 years of age.
Using Calcipotriol/Betamethasone ratiopharm with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. If your doctor agrees that you can breastfeed, be careful and do not apply Calcipotriol/Betamethasone ratiopharm to the breast area.
Driving and using machines
This medicine does not affect your ability to drive or use machines.
Calcipotriol/Betamethasone ratiopharmcontains butylhydroxytoluene (E321).
It may cause local skin reactions (such as contact dermatitis) or irritation of the eyes and mucous membranes.
Follow exactly the instructions of administration of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist.
How to use Calcipotriol/Betamethasone ratiopharm: topical use.
Instructions for proper use
Duration of treatment
If you are using other medicines that contain calcipotriol, the total amount of medicines containing calcipotriol should not exceed 15 grams per day, and the treated area should not exceed 30% of the total body surface area.
What to expect when using Calcipotriol/Betamethasone ratiopharm
Most patients notice obvious results after 2 weeks, even if the psoriasis has not completely cleared at that time.
If you use more Calcipotriol/Betamethasone ratiopharmthan you should
Consult your doctor if you have used more than 15 grams in one day. Excessive use of Calcipotriol/Betamethasone ratiopharm may cause a problem with the calcium in your blood, which usually normalizes when treatment is stopped.
Your doctor may need to perform blood tests to check that the use of too much ointment has not caused a problem with the calcium in your blood. Prolonged and excessive use may also cause your adrenal glands to stop working properly (these are located near the kidneys and produce hormones).
Contact the Toxicological Information Service, phone 91 562 04 20, indicating the medicine and the amount used.
If you forget to use Calcipotriol/Betamethasone ratiopharm
Do not apply a double dose to make up for forgotten doses.
If you stop treatment with Calcipotriol/Betamethasone ratiopharm
The use of Calcipotriol/Betamethasone ratiopharm should be stopped as indicated by your doctor. It may be necessary to stop using this medicine gradually, especially if you have been using it for a long time.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Tell your doctor/nurse immediately or as soon as possible if you experience any of the following side effects. You may need to stop your treatment.
The following serious side effects have been reported for Calcipotriol/Betamethasone ratiopharm:
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
It is known that some serious side effects are caused by betamethasone (a potent steroid), one of the components of Calcipotriol/Betamethasone ratiopharm. If you experience any of these serious side effects, inform your doctor as soon as possible. These side effects are more likely to occur after long-term use, use in skin folds (e.g., groin, armpits, or under the breasts), use under dressings or bandages, or use on large areas of skin.
Side effects include the following:
Serious side effects known to be caused by Calcipotriol
Less serious side effects
The following less serious side effects have been reported for Calcipotriol/Betamethasone ointment.
Common side effects (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Frequency not known (cannot be estimated from the available data):
Less serious side effects caused by the use of betamethasone, especially during prolonged use, include the following. If you notice any of them, inform your doctor or nurse as soon as possible.
Less serious side effects caused by calcipotriol include
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines, https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the SIGRE collection point at your pharmacy. If you have any doubts, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Calcipotriol/Betamethasone ratiopharm
The active substances are: calcipotriol and betamethasone.
One gram of ointment contains 50 micrograms of calcipotriol and 0.5 mg of betamethasone (as 0.643 mg of betamethasone dipropionate).
The other ingredients are:
Appearance of the product and pack contents
Calcipotriol/Betamethasone ratiopharm is a white to yellowish ointment that comes in aluminum tubes with a polyethylene cap.
Package sizes: 30, 60, and 120 g.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Teva Pharma, S.L.U.
C/ Anabel Segura, 11. Edificio Albatros B, 1ª planta
28108 Alcobendas, Madrid
Spain
Manufacturer
Teva Operations Poland Sp. z.o.o
ul. Mogilska 80.
31-546, Krakow
Poland
or
Pliva Croatia Ltd.
Prilaz baruna, Filipovica 25
10000 Zagreb (Croatia)
Date of last revision of this leaflet: August 2021
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of CALCIPOTRIOL/BETAMETHASONE RATIOPHARM 50 micrograms/g + 0.5 mg/g OINTMENT in November, 2025 is around 44.69 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for CALCIPOTRIOL/BETAMETHASONE RATIOPHARM 50 micrograms/g + 0.5 mg/g OINTMENT – subject to medical assessment and local rules.